| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | recombination hotspot binding | 2.49e-06 | 2 | 32 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.92e-04 | 13 | 32 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.64e-04 | 20 | 32 | 2 | GO:0042800 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 1.22e-05 | 4 | 30 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 1.22e-05 | 4 | 30 | 2 | GO:0010520 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 8.34e-05 | 1342 | 30 | 9 | GO:0033043 | |
| GeneOntologyBiologicalProcess | reciprocal meiotic recombination | 1.25e-04 | 67 | 30 | 3 | GO:0007131 | |
| GeneOntologyBiologicalProcess | reciprocal homologous recombination | 1.25e-04 | 67 | 30 | 3 | GO:0140527 | |
| GeneOntologyBiologicalProcess | organelle fission | 1.48e-04 | 571 | 30 | 6 | GO:0048285 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | 1.52e-04 | 574 | 30 | 6 | GO:0010638 | |
| GeneOntologyBiologicalProcess | homologous recombination | 1.68e-04 | 74 | 30 | 3 | GO:0035825 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 1.75e-04 | 75 | 30 | 3 | GO:0051785 | |
| Domain | SSXRD | 6.48e-05 | 8 | 29 | 2 | PF09514 | |
| Domain | SSXRD_motif | 6.48e-05 | 8 | 29 | 2 | IPR019041 | |
| Domain | KRAB_RELATED | 1.27e-04 | 11 | 29 | 2 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 1.80e-04 | 13 | 29 | 2 | IPR003655 | |
| Domain | SET | 2.31e-03 | 46 | 29 | 2 | SM00317 | |
| Domain | SET_dom | 2.72e-03 | 50 | 29 | 2 | IPR001214 | |
| Domain | SET | 2.72e-03 | 50 | 29 | 2 | PS50280 | |
| Domain | SPRY | 8.03e-03 | 87 | 29 | 2 | SM00449 | |
| Domain | SPRY | 9.31e-03 | 94 | 29 | 2 | PF00622 | |
| Domain | SPRY_dom | 9.31e-03 | 94 | 29 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 9.51e-03 | 95 | 29 | 2 | IPR001870 | |
| Domain | B302_SPRY | 9.51e-03 | 95 | 29 | 2 | PS50188 | |
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 4.92e-06 | 4 | 32 | 2 | 18231586 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.08e-05 | 560 | 32 | 6 | 21653829 | |
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 1.23e-05 | 6 | 32 | 2 | 17439945 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 16287854 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 10668202 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 14675547 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 24262428 | ||
| Pubmed | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. | 3.82e-05 | 419 | 32 | 5 | 27107012 | |
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 21624358 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 33888907 | ||
| Pubmed | 3.75e-04 | 31 | 32 | 2 | 21441570 | ||
| Pubmed | Ubiquitin chain elongation requires E3-dependent tracking of the emerging conjugate. | 4.25e-04 | 33 | 32 | 2 | 25306918 | |
| Pubmed | 4.79e-04 | 35 | 32 | 2 | 23716698 | ||
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 5.95e-04 | 39 | 32 | 2 | 16510873 | |
| Pubmed | Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. | 5.95e-04 | 39 | 32 | 2 | 24703692 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 6.25e-04 | 182 | 32 | 3 | 32239614 | |
| Pubmed | 6.71e-04 | 777 | 32 | 5 | 35844135 | ||
| Interaction | RAP2C interactions | 1.69e-06 | 55 | 32 | 4 | int:RAP2C | |
| Interaction | MMACHC interactions | 2.44e-06 | 17 | 32 | 3 | int:MMACHC | |
| Interaction | LAMA2 interactions | 6.30e-06 | 23 | 32 | 3 | int:LAMA2 | |
| Interaction | SAMM50 interactions | 1.67e-05 | 205 | 32 | 5 | int:SAMM50 | |
| Interaction | PGAM4 interactions | 3.45e-05 | 40 | 32 | 3 | int:PGAM4 | |
| Interaction | PTGR3 interactions | 4.30e-05 | 43 | 32 | 3 | int:PTGR3 | |
| Interaction | ODAPH interactions | 6.38e-05 | 49 | 32 | 3 | int:ODAPH | |
| Interaction | DYNC1I2 interactions | 9.46e-05 | 295 | 32 | 5 | int:DYNC1I2 | |
| Interaction | PSMA1 interactions | 9.47e-05 | 480 | 32 | 6 | int:PSMA1 | |
| Interaction | ANXA2P2 interactions | 9.52e-05 | 56 | 32 | 3 | int:ANXA2P2 | |
| Interaction | GNB1 interactions | 1.14e-04 | 307 | 32 | 5 | int:GNB1 | |
| Cytoband | 1p36.22 | 3.09e-04 | 37 | 32 | 2 | 1p36.22 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 9.91e-05 | 17 | 16 | 2 | 1197 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.40e-02 | 206 | 16 | 2 | 682 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.65e-06 | 164 | 32 | 4 | a5227971a71345854e0538e42da684de87febda0 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-06 | 168 | 32 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 175 | 32 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.81e-06 | 178 | 32 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-06 | 178 | 32 | 4 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class (2021.01.30) | 1.07e-05 | 193 | 32 | 4 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 197 | 32 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | 1779a8ff4443a85ac500f849764e86d9c7529b84 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 1.85e-04 | 155 | 32 | 3 | d4ef25965a15eab7679478b9b661e1b4a92f1c59 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.88e-04 | 156 | 32 | 3 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.88e-04 | 156 | 32 | 3 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.99e-04 | 159 | 32 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-4|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.07e-04 | 161 | 32 | 3 | 047901a314c079ad19814beca33922a001960ad8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.14e-04 | 163 | 32 | 3 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.30e-04 | 167 | 32 | 3 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 170 | 32 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.51e-04 | 172 | 32 | 3 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.51e-04 | 172 | 32 | 3 | a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 174 | 32 | 3 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 176 | 32 | 3 | e08e7a6dd0208acfbb8646d71915af822a64b5de | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 176 | 32 | 3 | b8264cdda75c5145d8bf8ae00b3e05393fe9a92b | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 176 | 32 | 3 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 176 | 32 | 3 | 4aee9fdada077db7e531684ab938153f84dc8146 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-04 | 178 | 32 | 3 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-04 | 178 | 32 | 3 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-04 | 181 | 32 | 3 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-04 | 181 | 32 | 3 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.11e-04 | 185 | 32 | 3 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-04 | 185 | 32 | 3 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-04 | 185 | 32 | 3 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.16e-04 | 186 | 32 | 3 | 86d145f965c311189e7996390eef491642417c5c | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 186 | 32 | 3 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.31e-04 | 189 | 32 | 3 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 2e164d5a79ffbab93985be5bd8a513fdf597c673 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 191 | 32 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.57e-04 | 194 | 32 | 3 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 195 | 32 | 3 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 195 | 32 | 3 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-04 | 195 | 32 | 3 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.68e-04 | 196 | 32 | 3 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.73e-04 | 197 | 32 | 3 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.73e-04 | 197 | 32 | 3 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 3.73e-04 | 197 | 32 | 3 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | COVID-19_Severe-cDC|COVID-19_Severe / Disease condition and Cell class | 3.79e-04 | 198 | 32 | 3 | e0b16627a347e245bedd71b1e0ccdb46c1c1bd6d | |
| ToppCell | COVID-19_Severe-cDC-|COVID-19_Severe / Disease condition and Cell class | 3.79e-04 | 198 | 32 | 3 | 3914140238598914674c08c5ad83354b9485825f | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-04 | 199 | 32 | 3 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-04 | 199 | 32 | 3 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.85e-04 | 199 | 32 | 3 | 624a807fae0a080a4e6755dcb374c25b6f2d2cfe | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-MEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.90e-04 | 200 | 32 | 3 | 53160551d558148d1d80ec87b90dd6be7d36e4c7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.90e-04 | 200 | 32 | 3 | af4d922659b6f9d446797f7a3922a211e22f88e4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.90e-04 | 200 | 32 | 3 | 88e94b067da1068b2ff1f95c730f2a49c66d7fe6 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.90e-04 | 200 | 32 | 3 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.90e-04 | 200 | 32 | 3 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.90e-04 | 200 | 32 | 3 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.90e-04 | 200 | 32 | 3 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.12e-06 | 188 | 32 | 5 | 6451_DN | |
| Disease | hypertrophic cardiomyopathy | 1.36e-04 | 92 | 32 | 3 | EFO_0000538 | |
| Disease | glaucoma | 6.19e-04 | 154 | 32 | 3 | MONDO_0005041 | |
| Disease | right ventricular systolic volume measurement | 6.63e-04 | 35 | 32 | 2 | EFO_0021815 | |
| Disease | age at first sexual intercourse measurement | 7.54e-04 | 383 | 32 | 4 | EFO_0009749 | |
| Disease | health study participation | 1.22e-03 | 195 | 32 | 3 | EFO_0010130 | |
| Disease | schizophrenia, anorexia nervosa | 1.25e-03 | 48 | 32 | 2 | MONDO_0005090, MONDO_0005351 | |
| Disease | risk-taking behaviour | 1.29e-03 | 764 | 32 | 5 | EFO_0008579 | |
| Disease | fat body mass | 1.66e-03 | 217 | 32 | 3 | EFO_0005409 | |
| Disease | urate measurement, spine bone mineral density | 1.81e-03 | 58 | 32 | 2 | EFO_0004531, EFO_0007701 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.88e-03 | 59 | 32 | 2 | EFO_0009658, GO_0009410 | |
| Disease | response to opioid | 2.00e-03 | 61 | 32 | 2 | EFO_0008541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLEERDNMIQNCNRE | 151 | Q6TFL3 | |
| CQQMEREERENNLPE | 811 | O14490 | |
| ADRLQRQEEERMNCS | 106 | Q9Y243 | |
| EELRNIELECQNIMQ | 671 | Q6ZMN7 | |
| QQRFDELCSRLNMDE | 46 | Q08999 | |
| VDSADRQRMQDCQRE | 91 | P36404 | |
| DRLMQQLQDLEECRE | 21 | Q8WZA0 | |
| EEKMQEQLERNRQCQ | 121 | Q9Y6D9 | |
| EEQLAQLRCEMEQQN | 381 | P02533 | |
| REKDDIQRAECMLQQ | 326 | P13796 | |
| VDVNECDELNNRMSL | 1661 | Q14766 | |
| DMENNVLFRDDIECQ | 421 | Q96PQ7 | |
| QQVYCEEMREERQDR | 386 | O95140 | |
| MRYVNCARDDEEQNL | 316 | Q9NQV7 | |
| VDFDQLQDNLCQMER | 1156 | Q2V2M9 | |
| ENRRDMEAEEENQIN | 101 | A8MZ97 | |
| RNTEENLELQMEDCE | 326 | Q5T5S1 | |
| RQRLMQCDLEEEENV | 496 | P57679 | |
| ADENEMINCEEFANR | 4116 | P21817 | |
| ENAVRMDEARDNACN | 31 | Q99622 | |
| QLETEQREEQCREME | 71 | Q13371 | |
| NDRNSMDIQCEVDAL | 156 | Q02241 | |
| MNCEREQLRGNQEAA | 1 | Q9NWB1 | |
| AQEQLERMRRNQECG | 591 | Q9H4M7 | |
| MRYVNCARDDEEQNL | 316 | Q9NQW5 | |
| EVERNLQDAMQVCRN | 386 | P49368 | |
| NMRLDCVQELLQDEE | 366 | O15457 | |
| LQEDLCRMQNELEDM | 171 | Q96JN2 | |
| QMEQCELLEDQRRMQ | 561 | Q96JN2 | |
| QLCEEERRAMQAALD | 416 | Q8WVR3 | |
| EENIDRMCQDLRNQL | 96 | Q8WVM8 | |
| EQADSCREQLDIMND | 146 | Q14142 | |
| CREQLDIMNDLSNRV | 151 | Q14142 | |
| VNEDCNERILAMRAE | 126 | Q2TAA8 |